NCT03824821 (IBSQUtrition) is a clinical trial of No intervention in Irritable Bowel Syndrome, sponsored by Wageningen University.

Who is sponsoring NCT03824821?

NCT03824821 is sponsored by Wageningen University.

What drugs are being tested in NCT03824821?

Interventions in NCT03824821: No intervention.

What condition does NCT03824821 study?

NCT03824821 studies Irritable Bowel Syndrome.

Is NCT03824821 still recruiting?

NCT03824821 is currently completed. Last updated 31 January 2019.

Last reviewed 2019-01-31 · How we verify

NCT03824821: IBSQUtrition

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessing Associations Between IBS Symptoms, Nutrition and QoL in IBS Patients Using a Questionnaire

Completed Last updated 31 January 2019

What this trial tests

trial testing No intervention in Irritable Bowel Syndrome in 2,076 participants. Completed in 31 May 2018.

Timeline

22 January 2018

Primary endpoint
31 May 2018

31 May 2018

Quick facts

Lead sponsor	Wageningen University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	2,076
Start date	22 January 2018
Primary completion	31 May 2018
Estimated completion	31 May 2018
Sites	1 location across Netherlands

Drugs / interventions tested

No intervention

Conditions studied

Irritable Bowel Syndrome — all drugs for Irritable Bowel Syndrome →

Sponsor

Wageningen University

Who can join

18 and older, any sex, with Irritable Bowel Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a cross-sectional observational study design that aimed to include 2000 IBS patients. We used several validated questionnaires, to assess IBS characteristics (such as subtype, severity), psychological features (QoL, anxiety and depression) and assess nutritional triggers. Subjects filled in the questionnaire online, and was spread across the Netherlands.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
NCT07540611 — Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive · NA · not yet recruiting
NCT07291778 — Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness · NA · not yet recruiting
NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting

Other recruiting trials for Irritable Bowel Syndrome

Currently open trials in the same condition.

NCT07235228 — Effects of Vivatlac Synbiotic on Gut Micribiota of IBS Patients · NA · recruiting
NCT07421011 — Pharmacokinetics, Bioequivalence, and Safety Study of Trimedat® 76,95 mg Orally Disintegrating Tablets and Trimedat® 100 · Phase 1 · recruiting
NCT07360938 — Drug Interaction Potential of Pro-Inflammatory Conditions · recruiting
NCT06788444 — Efficacy of Esketamine for Patients With Irritable Bowel Syndrome · NA · recruiting
NCT07484412 — Efficacy and Safety of Encapsulated Bifidobacterium Longum BBH016 in Subjects With Lower Gastrointestinal Symptoms · NA · active not recruiting

Other Wageningen University trials

Trials by the same sponsor.

NCT07361406 — SweetSpot - The Effect of Non-nutritive Sweeteners on Health · NA · recruiting
NCT07421466 — Umami Taste Intensity and Meal Intake · NA · completed
NCT07075991 — Uptake and Excretion of a Single Dose of Oral 14C-labelled Polystyrene Microplastics in Healthy Volunteers · NA · completed
NCT07059117 — Umami Taste Intensity and ad Libitum Meal Intake · NA · completed
NCT06750497 — Forearm Immobilization in T2D · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03824821 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Wageningen University
Last refreshed: 31 January 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03824821.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing